NCT03140280View on ClinicalTrials.gov

Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

June 1, 2019

Study Completion Date

May 28, 2021

Conditions
Myelodysplastic Syndromes
Interventions
DRUG

Freeze-Dried Black Raspberry Powder

25 gm (2x/day) of freeze-dried black raspberry powder taken orally in 8 ounces of water for 12 weeks. If the patient is tolerating BRBs well and is benefiting from therapy, he or she will continue treatment for a total maximum of 48 weeks.

Trial Locations (1)

53226

Froedtert & the Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Ehab L Atallah

OTHER

NCT03140280 - Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) | Biotech Hunter | Biotech Hunter